Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20494 | YW2065 | 2131223-85-1 | 98% Min. |  |
| YW2065 has excellent anti-colorectal cancer effects in vitro and in vivo. YW2065 achi | ||||
| 21241 | YKL-05-099 | 1936529-65-5 | 98% Min. |  |
| YKL-05-099 is a selective inhibitor of Salt-Inducible Kinase (SIK). | ||||
| 2073105 | YCN47284 | 181147-28-4 | 98% Min. |  |
| YCN47284 is an aromatic guanylhydrazone compounds with antimalarial activity. | ||||
| 2071610 | YUN27078 | 879127-07-8 | 98% Min. |  |
| YUN27078, also known as EGFR inhibitor, is an EGFR inhibitor. It directly depolymeriz | ||||
| 193193 | Y06137 | 2226534-49-0 | >98% |  |
| Y06137 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomai | ||||
| 193151 | YF-2 hydrochloride | 1312005-62-1 | >98% |  |
| YF-2 hydrochloride is a highly selective, blood-brain-barrier permeable histone acety | ||||
| 192213 | YH239-EE | 1364488-67-4 | >98% |  |
| YH239-EE is a highly potent p53-MDM2 antagonist. | ||||
| 185172 | Y-39983 free base | 199433-58-4 | >98% |  |
| Y-39983 (free base), also known as Y-33075, is a potent and selective inhibitor of RO | ||||
| 18578 | YL-0919 | 1339058-04-6 | >98% |  |
| YL-0919 is a novel 5-HT1A receptor agonist and selective serotonin reuptake inhibitor. | ||||
| 1710139 | YU-238259 | 1943733-16-1 | >98% |  |
| YU238259 exhibits potent synthetic lethality in the setting of DNA damage response an | ||||
| 1791521 | Y-29794 Tosylate | 143984-17-2 | 98.0% |  |
| Y-29794 Tosylate is an orally active, potent and specific non-peptide prolyl endopept | ||||
| 17030112 | Y15 hydrochloride | 4506-66-5 | 98% |  |
| Y15 hydrochloride, also known as FAK Inhibitor 14, is a direct FAK autophosphorylatio | ||||
| 17021305 | Y-39983 HCl | 173897-44-4 | 98% |  |
| Y-39983 is a selective rho-associated protein kinase(ROCK) inhibitor with an IC50 o | ||||
| 17021302 | 740 Y-P (PDGFR 740Y-P) | 1236188-16-1 | 98% | |
| 740 Y-P is cell-permeable phosphopeptide activator ofPI3K. The PDGFR 740Y-P peptide s | ||||
| 17109009 | YM-58483 (BTP2) | 223499-30-7 | 98% | -cas-223499-30-7.png) |
| YM-58483/BTP2 is a blocker of store-operated Ca2+ entry (SOCE), which regulates the a | ||||
| 16122849 | YM-90709 | 163769-88-8 | 98% |  |
| YM-90709 is an interleukin-5 receptor antagonist. YM-90709 inhibits the binding of IL | ||||
| 16122848 | Y-29794 Tosylate | 129184-48-1 | 98% |  |
| Y-29794 Tosylate is an orally active, potent and specific non-peptide prolyl endopept | ||||
| 6111512 | YHO-13351 | 1346753-00-1 | 98% |  |
| YHO-13351 is the water-soluble prodrug of YHO-13177, which is a potent and specific i | ||||
| 6111511 | YHO-13177 | 912287-56-0 | 98% | |
| YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of | ||||
| 6111414 | YM-155 hydrochloride | 355406-09-6 | 98% |  |
| YM155 is a potent survivin suppressant by inhibiting Survivin promoter activity with | ||||
| 611813 | YLF-466D | 1273323-67-3 | 98% | |
| YLF-466D is an allosteric AMPK activator.YLF466D activated recombinant human 111, 211 | ||||
| 16070918 | Y27632(free base) | 146986-50-7 | 98% by HPLC | -cas-146986-50-7.png) |
| Y27632 is a selective ROCK inhibitor, which inhibits ET-1-induced increases in natriu | ||||
| 030910 | YK11 | 1370003-76-1 | 98% |  |
| Coming soon! | ||||
| 010421 | Y-27632 dihydrochloride | 129830-38-2 | 97% |  |
| Y-27632 2Hcl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM, exhibits &g | ||||
| 121426 | YM-201636 | 371942-69-7 | 98% |  |
| YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM, less potent to p110. | ||||
| 110219 | YL-109 | 36341-25-0 | 98% |  |
| YL-109 has ability to inhibit breast cancer cell growth and invasiveness in vitro and | ||||
| 52516 | Y-320 | 288250-47-5 | 98% | |
| Y-320 is a new phenylpyrazoleanilide immunomodulator; inhibits IL-17 production by CD | ||||